https://www.selleckchem.com/products/dasa-58.html
A large proportion of patients with infectious mononucleosis (IM) have abnormal liver function tests (LFT) at presentation. There is no guideline regarding the management and follow-up of these patients. Some patients also have abdominal ultrasound (US) due to deranged LFT, the need for this practice is unclear. The aim of this systematic review was to evaluate the evidence base on LFT assessment in IM, time to resolution of derangement, and the role of abdominal US. A systematic search of PubMed, EMBASE and the Cochrane library was don
Gefällt mir
Kommentar
Teilen
